Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1678766

Cover Image

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1678766

Japan Digital Health Market - 2025-2033

PUBLISHED:
PAGES: 176 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 3175
PDF & Excel (Multiple User License)
USD 3500
PDF & Excel (Enterprise License)
USD 6850

Add to Cart

The Japan digital health market reached US$ 10.96 billion in 2024 and is expected to reach US$ 51.42 million by 2033, growing at a CAGR of 19.0% during the forecast period of 2025-2033.

Digital health refers to using digital technologies to improve healthcare delivery, enhance health outcomes, and promote a patient's overall well-being. This rapidly growing field integrates technology such as mobile apps, wearables, artificial intelligence (AI), telemedicine, and electronic health records (EHRs) into various aspects of healthcare. The objective is to enhance the efficiency, accessibility, and quality of care, making healthcare services more personalized, timely, and effective.

Digital health solutions facilitate better coordination of care across various healthcare providers, improving patient experiences and reducing fragmented care. As technology continues to evolve, digital health is expected to further revolutionize how healthcare is delivered, offering more accessible, efficient, and patient-centered services.

Market Dynamics: Drivers & Restraints

Rising Geriatric Population

Japan's aging population is a key driver of the digital health market, as the demand for healthcare services increases due to the higher prevalence of chronic diseases and the need for long-term care. Digital health solutions, such as telemedicine, remote monitoring, wearables, and AI-driven tools, are essential in addressing these challenges by enabling elderly individuals to access care remotely, track vital health metrics in real time, and manage chronic conditions more effectively.

These technologies not only provide personalized care but also reduce the burden on healthcare providers, particularly in rural areas where there is a shortage of professionals. Additionally, innovations like assistive robots and smart home solutions are improving the daily lives of elderly people. With government support through initiatives like the "Healthcare Policy 2025," digital health solutions are increasingly integrated into Japan's healthcare system, ensuring that elderly citizens can receive the care they need while improving overall healthcare efficiency and accessibility.

Technical Limitations

Technical limitations are expected to significantly hinder the growth of Japan's digital health market in several ways. Despite Japan's strong technological infrastructure, challenges such as insufficient interoperability between healthcare systems, outdated software, and lack of standardized data formats can limit the seamless integration of digital health solutions.

Segment Analysis

The Japan digital health market is segmented based on component, type, and end-user.

Type:

mHealth in the type segment is expected to dominate in the Japan digital health market.

Japan has a high smartphone penetration rate and a tech-savvy population, making mobile health applications and services highly accessible and widely adopted. The aging population, in particular, is a major driver for mHealth solutions, as mobile apps and wearables can help older adults monitor their health, track vital signs, and manage chronic conditions without requiring frequent visits to healthcare providers.

mHealth solutions, such as health tracking apps, medication reminders, and telemedicine platforms, offer convenience and flexibility for patients, empowering them to take charge of their health. Moreover, Japan's focus on preventative care and wellness aligns with the growing use of mHealth tools that promote healthier lifestyles, encourage regular physical activity, and track diet and sleep. As more healthcare providers and patients embrace mobile solutions for daily health management, the mHealth segment is expected to lead Japan's digital health market growth by offering efficient, accessible, and personalized healthcare options.

Competitive Landscape

The major players in Japan digital health market include Takeda Pharmaceutical Company Limited, OMRON Corporation, CureApp, Shionogi & Co., Ltd., HealthNode, Whill, Allm Inc., Dai-ichi Life Holdings, Inc., Xiaomi, and Hitachi Energy Ltd., among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials and product pipelines and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyze product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Japan Digital Health Market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.
Product Code: HCIT9209

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Component
  • 3.2. Snippet by Type
  • 3.3. Snippet by End-User

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Geriatric Population
      • 4.1.1.2. Increasing Adoption of Advanced Technologies in Home Healthcare
    • 4.1.2. Restraints
      • 4.1.2.1. Technical Limitations
      • 4.1.2.2. Data Privacy Concerns
    • 4.1.3. Opportunity
      • 4.1.3.1. Increasing Strategic Initiatives by Market Players
  • 4.2. Impact Analysis

5. Strategic Insights and Industry Outlook

  • 5.1. Market Leaders and Pioneers
    • 5.1.1. Emerging Pioneers and Prominent Players
    • 5.1.2. Established leaders with largest selling Brand
    • 5.1.3. Market leaders with established Product
  • 5.2. CXO Perspectives
  • 5.3. Latest Developments and Breakthroughs
  • 5.4. Case Studies/Ongoing Research
  • 5.5. Regulatory and Reimbursement Landscape
  • 5.6. Porter's Five Forces Analysis
  • 5.7. Supply Chain Analysis
  • 5.8. Patent Analysis
  • 5.9. SWOT Analysis
  • 5.10. Unmet Needs and Gaps
  • 5.11. Recommended Strategies for Market Entry and Expansion
  • 5.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 5.13. Pricing Analysis and Price Dynamics
  • 5.14. Key Opinion Leaders

6. By Component

  • 6.1. Introduction
    • 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Component
    • 6.1.2. Market Attractiveness Index, By Component
  • 6.2. Hardware*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Software
  • 6.4. Services

7. By Type

  • 7.1. Introduction
    • 7.1.1. Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. mHealth*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. eHealth
  • 7.4. Telehealthcare
  • 7.5. Health Analytics
  • 7.6. Others

8. By End-User

  • 8.1. Introduction
    • 8.1.1. Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Healthcare Providers*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Healthcare Consumers
  • 8.4. Others

9. Competitive Landscape

  • 9.1. Competitive Scenario
  • 9.2. Market Positioning/Share Analysis
  • 9.3. Mergers and Acquisitions Analysis

10. Company Profiles

Key Market Players

  • 10.1. OMRON Corporation*
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio
      • 10.1.2.1. Product Description
      • 10.1.2.2. Product Key Performance Indicators (KPIs)
      • 10.1.2.3. Historic and Forecasted Product Sales
    • 10.1.3. Financial Overview
      • 10.1.3.1. Company Revenue's
      • 10.1.3.2. Geographical Revenue Shares
      • 10.1.3.3. Revenue Forecasts
    • 10.1.4. Key Developments
      • 10.1.4.1. Mergers & Acquisitions
      • 10.1.4.2. Key Product Development Activities
      • 10.1.4.3. Regulatory Approvals, etc.
    • 10.1.5. SWOT Analysis
  • 10.2. CureApp
  • 10.3. Shionogi & Co., Ltd.
  • 10.4. HealthNode
  • 10.5. Whill
  • 10.6. Allm Inc.
  • 10.7. Dai-ichi Life Holdings, Inc.
  • 10.8. Xiaomi
  • 10.9. Hitachi Energy Ltd.
  • Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

11. Appendix

  • 11.1. About Us and Services
  • 11.2. Contact Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!